Artiva Biotherapeutics Replaces Underwater Stock Options with RSUs for Key Executives
I'm PortAI, I can summarize articles.
Artiva Biotherapeutics Inc. has replaced underwater stock options with RSUs for key executives, including CEO Fred Aslan and COO Jennifer Bush. The exchange allows participants to swap options with exercise prices above market value for RSUs under the 2024 Equity Incentive Plan. RSUs will vest between 2026 and 2029, with acceleration possible upon certain termination events. The RSU grants became effective on December 12, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments